The Pharmaceutical Solid Dosage Contract Manufacturing market was valued at US$ xx in 2023. The market for Pharmaceutical Solid Dosage Contract Manufacturing is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. The report offers detailed coverage of Pharmaceutical Solid Dosage Contract Manufacturing industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pharmaceutical Solid Dosage Contract Manufacturing by geography. The report splits the market size, by volume and value, on the basis of application type and geography. In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Pharmaceutical Solid Dosage Contract Manufacturing market are discussed. The market is segmented by types: Tablets Capsule Lozenge Powder Others It can be also divided by applications: Instant Release Sustained Release Extended Release Effervescent Tablets Chewable Tablets Enteric Release And this report covers the historical situation, present status and the future prospects of the global Pharmaceutical Solid Dosage Contract Manufacturing market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America. Finally, the report provides detailed profile and data information analysis of leading company. Abbott Laboratories Catalent Pharma Solutions Jubilant Life Sciences Limited Alkermes BioPharma Solutions Cytovance Biologics DPT Laboratories Fresenius Kabi Halo Pharmaceutical Lyophilization Technology Mikart Pillar5 Pharma Haupt Pharma Althea Technologies Associates of Cape Cod Covance Emergent BioSolutions Report Includes: - xx data tables and xx additional tables - An overview of global Pharmaceutical Solid Dosage Contract Manufacturing market - An detailed key players analysis across regions - Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031 - Insights into regulatory and environmental developments - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Pharmaceutical Solid Dosage Contract Manufacturing market - Profiles of major players in the industry, including Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Alkermes, BioPharma Solutions..... Research objectives To study and analyze the global Pharmaceutical Solid Dosage Contract Manufacturing consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031. To understand the structure of Pharmaceutical Solid Dosage Contract Manufacturing market by identifying its various subsegments. Focuses on the key global Pharmaceutical Solid Dosage Contract Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years. To analyze the Pharmaceutical Solid Dosage Contract Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the consumption of Pharmaceutical Solid Dosage Contract Manufacturing submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents Global Pharmaceutical Solid Dosage Contract Manufacturing Market Report 2024, Forecast to 2031 1 Scope of the Study 1.1 Pharmaceutical Solid Dosage Contract Manufacturing Introduction 1.2 Research Programs 1.3 Analysis of Macroeconomic Indicators 1.4 Years Considered 1.5 Methodology 1.6 Data Source 1.7 Research Objectives 2 Pharmaceutical Solid Dosage Contract Manufacturing Industry Overview 2.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size (Million USD) Comparison by Regions (2024-2031) 2.1.1 Pharmaceutical Solid Dosage Contract Manufacturing Global Main Region Market Analysis 2.2 Market Analysis by Type 2.2.1 Tablets 2.2.2 Capsule 2.2.3 Lozenge 2.2.4 Powder 2.2.5 Others 2.3 Market Analysis by Application 2.3.1 Instant Release 2.3.2 Sustained Release 2.3.3 Extended Release 2.3.4 Effervescent Tablets 2.3.5 Chewable Tablets 2.3.6 Enteric Release 2.4 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue, Sales and Market Share by Manufacturer 2.4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Sales and Market Share by Manufacturer (2019-2023) 2.4.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Manufacturer (2019-2023) 2.4.3 Global Pharmaceutical Solid Dosage Contract Manufacturing Industry Concentration Ratio (CR5 and HHI) 2.4.4 Top 5 Pharmaceutical Solid Dosage Contract Manufacturing Manufacturer Market Share 2.4.5 Top 10 Pharmaceutical Solid Dosage Contract Manufacturing Manufacturer Market Share 2.4.6 Date of Key Manufacturers Enter into Pharmaceutical Solid Dosage Contract Manufacturing Market 2.4.7 Key Manufacturers Pharmaceutical Solid Dosage Contract Manufacturing Product Offered 2.4.8 Mergers & Acquisitions Planning 2.5 Pharmaceutical Solid Dosage Contract Manufacturing Historical Development Overview 2.6 Market Dynamics 2.6.1 Market Opportunities 2.6.2 Market Risk 2.6.3 Market Driving Force 2.6.4 Porter's Five Forces Analysis 2.7 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Solid Dosage Contract Manufacturing Industry Impact 2.7.1 How the Covid-19 is Affecting the Pharmaceutical Solid Dosage Contract Manufacturing Industry 2.7.2 Pharmaceutical Solid Dosage Contract Manufacturing Business Impact Assessment - Covid-19 2.7.3 Market Trends and Pharmaceutical Solid Dosage Contract Manufacturing Potential Opportunities in the COVID-19 Landscape 2.7.4 Measures / Proposal against Covid-19 3 Related Market Analysis 3.1 Related Market Overview 3.2 Macro Analysis of Upstream Markets 3.3 Key Players in Related Markets 3.4 Related Markets Trend Analysis 4 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Regions 4.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Regions 4.1.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Sales and Market Share by Regions (2019-2023) 4.1.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Regions (2019-2023) 4.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 4.3 APAC Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 4.4 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 4.5 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 4.6 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5 Europe Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Countries 5.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Countries 5.1.1 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Countries (2019-2023) 5.1.2 Germany Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.1.3 UK Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.1.4 France Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.1.5 Russia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.1.6 Italy Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.1.7 Spain Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 5.2 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Value) by Manufacturers (2019-2023) 5.3 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 5.4 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Application (2019-2023) 6 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Countries 6.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Countries 6.1.1 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Countries (2019-2023) 6.1.2 China Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.1.3 Japan Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.1.4 Korea Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.1.5 India Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.1.6 Southeast Asia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.1.7 Australia Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 6.2 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Value) by Players (2019-2023) 6.3 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 6.4 Asia-Pacific Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Application (2019-2023) 7 North America Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Countries 7.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Countries 7.1.1 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Countries (2019-2023) 7.1.2 United States Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 7.1.3 Canada Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 7.1.4 Mexico Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 7.2 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Value) by Players (2019-2023) 7.3 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 7.4 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Application (2019-2023) 8 South America Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Countries 8.1 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Countries 8.1.1 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Countries (2019-2023) 8.1.2 Brazil Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 8.2 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Value) by Players (2019-2023) 8.3 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 8.4 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Application (2019-2023) 9 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Market Size Categorized by Countries 9.1 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Countries 9.1.1 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue by Countries (2019-2023) 9.1.2 GCC Countries Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 9.1.3 Turkey Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 9.1.4 Egypt Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 9.1.5 South Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Growth Rate (2019-2023) 9.2 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue (Value) by Players (2019-2023) 9.3 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 9.4 Middle East and Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Application (2019-2023) 10 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Segment by Type 10.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Market Share by Type (2019-2023) 10.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Forecast by Type (2024-2031) 10.3 Tablets Revenue Growth Rate 10.4 Capsule Revenue Growth Rate 10.5 Lozenge Revenue Growth Rate 10.6 Powder Revenue Growth Rate 10.7 Others Revenue Growth Rate 11 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Segment by Application 11.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Share by Application (2019-2023) 11.2 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Forecast by Application (2024-2031) 11.3 Instant Release Revenue Growth Rate (2015-2025) 11.4 Sustained Release Revenue Growth Rate (2015-2025) 11.5 Extended Release Revenue Growth Rate (2015-2025) 11.6 Effervescent Tablets Revenue Growth Rate (2015-2025) 11.7 Chewable Tablets Revenue Growth Rate (2015-2025) 11.8 Enteric Release Revenue Growth Rate (2015-2025) 12 Market Forecast for Pharmaceutical Solid Dosage Contract Manufacturing 12.1 Global Pharmaceutical Solid Dosage Contract Manufacturing Market Size Forecast (2024-2031) 12.2 Pharmaceutical Solid Dosage Contract Manufacturing Market Forecast by Regions (2024-2031) 12.3 Europe Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Forecast (2024-2031) 12.4 APAC Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Forecast (2024-2031) 12.5 North America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Forecast (2024-2031) 12.6 South America Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Forecast (2024-2031) 12.7 Middle East & Africa Pharmaceutical Solid Dosage Contract Manufacturing Revenue Market Forecast (2024-2031) 13 Analysis of Pharmaceutical Solid Dosage Contract Manufacturing Industry Key Vendors 13.1 Abbott Laboratories 13.1.1 Company Details 13.1.2 Product Information 13.1.3 Abbott Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.1.4 Main Business Overview 13.1.5 Abbott Laboratories News 13.2 Catalent Pharma Solutions 13.2.1 Company Details 13.2.2 Product Information 13.2.3 Catalent Pharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.2.4 Main Business Overview 13.2.5 Catalent Pharma Solutions News 13.3 Jubilant Life Sciences Limited 13.3.1 Company Details 13.3.2 Product Information 13.3.3 Jubilant Life Sciences Limited Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.3.4 Main Business Overview 13.3.5 Jubilant Life Sciences Limited News 13.4 Alkermes 13.4.1 Company Details 13.4.2 Product Information 13.4.3 Alkermes Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.4.4 Main Business Overview 13.4.5 Alkermes News 13.5 BioPharma Solutions 13.5.1 Company Details 13.5.2 Product Information 13.5.3 BioPharma Solutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.5.4 Main Business Overview 13.5.5 BioPharma Solutions News 13.6 Cytovance Biologics 13.6.1 Company Details 13.6.2 Product Information 13.6.3 Cytovance Biologics Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.6.4 Main Business Overview 13.6.5 Cytovance Biologics News 13.7 DPT Laboratories 13.7.1 Company Details 13.7.2 Product Information 13.7.3 DPT Laboratories Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.7.4 Main Business Overview 13.7.5 DPT Laboratories News 13.8 Fresenius Kabi 13.8.1 Company Details 13.8.2 Product Information 13.8.3 Fresenius Kabi Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.8.4 Main Business Overview 13.8.5 Fresenius Kabi News 13.9 Halo Pharmaceutical 13.9.1 Company Details 13.9.2 Product Information 13.9.3 Halo Pharmaceutical Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.9.4 Main Business Overview 13.9.5 Halo Pharmaceutical News 13.10 Lyophilization Technology 13.10.1 Company Details 13.10.2 Product Information 13.10.3 Lyophilization Technology Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.10.4 Main Business Overview 13.10.5 Lyophilization Technology News 13.11 Mikart 13.11.1 Company Details 13.11.2 Product Information 13.11.3 Mikart Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.11.4 Main Business Overview 13.11.5 Mikart News 13.12 Pillar5 Pharma 13.12.1 Company Details 13.12.2 Product Information 13.12.3 Pillar5 Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.12.4 Main Business Overview 13.12.5 Pillar5 Pharma News 13.13 Haupt Pharma 13.13.1 Company Details 13.13.2 Product Information 13.13.3 Haupt Pharma Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.13.4 Main Business Overview 13.13.5 Haupt Pharma News 13.14 Althea Technologies 13.14.1 Company Details 13.14.2 Product Information 13.14.3 Althea Technologies Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.14.4 Main Business Overview 13.14.5 Althea Technologies News 13.15 Associates of Cape Cod 13.15.1 Company Details 13.15.2 Product Information 13.15.3 Associates of Cape Cod Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.15.4 Main Business Overview 13.15.5 Associates of Cape Cod News 13.16 Covance 13.16.1 Company Details 13.16.2 Product Information 13.16.3 Covance Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.16.4 Main Business Overview 13.16.5 Covance News 13.17 Emergent BioSolutions 13.17.1 Company Details 13.17.2 Product Information 13.17.3 Emergent BioSolutions Pharmaceutical Solid Dosage Contract Manufacturing Revenue and Gross Margin (2019-2023) 13.17.4 Main Business Overview 13.17.5 Emergent BioSolutions News 14 Research Findings and Conclusion 15 Appendix